Source – Pregabalin prescribing patterns in Australian general practice, 2012–2018: a cross-sectional study[/caption]
National Medicines Symposium 2024 speakers (L to R): Steve Waller, Professor Jennifer Martin, Professor Libby Roughead, Tegan Taylor[/caption]
This CPD activity is sponsored by Reckitt. All content is the true, accurate and independent opinion of the speakers and the views expressed are entirely their own.[/caption]
The new normal
A new PSA report describes the digital future of Australian health care, a ‘new normal’ with pharmacists front and centre, equipped with more information...
Partnering with patients the most important healthcare standard
While health literacy is key, engaging and educating clinicians about the concept of patient choice is just as critical, a leading clinical expert said at the Choosing Wisely National Meeting yesterday.
Calculating the risk of glaucoma
More than 1000 people have completed an online assessment in Australian pharmacies to determine their potential risk of developing glaucoma, and there's a call...
Navigating South Pacific health care on a sea of data
A group of Melbourne pharmacists have developed a data aggregation and visualisation platform used for strengthening health supply chains, disaster response and improving health...
Hepatitis C deaths fall sharply but cure access dropping
The introduction of direct-acting antivirals therapies for hepatitis C in 2016 has contributed to a 20% decline in deaths attributed to the disease, but...
The effectiveness and safety of breast cancer medications
The purpose of this evidence summary is to present the best available evidence regarding the efficacy and safety of breast cancer prevention medications (CPM).
Background...
